OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The current paradigm and challenges ahead for the dormancy of disseminated tumor cells
Emma Risson, Ana Rita Nobre, Véronique Maguer‐Satta, et al.
Nature Cancer (2020) Vol. 1, Iss. 7, pp. 672-680
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Targeting metastatic cancer
Karuna Ganesh, Joan Massagué
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 34-44
Open Access | Times Cited: 682

The lingering mysteries of metastatic recurrence in breast cancer
Alessandra I. Riggio, Katherine E. Varley, Alana L. Welm
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 13-26
Open Access | Times Cited: 420

Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 293

TGF-β signaling in health and disease
Joan Massagué, Dean Sheppard
Cell (2023) Vol. 186, Iss. 19, pp. 4007-4037
Open Access | Times Cited: 245

Metastasis-Initiating Cells and Ecosystems
Joan Massagué, Karuna Ganesh
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 971-994
Open Access | Times Cited: 227

Persistent Cancer Cells: The Deadly Survivors
Shensi Shen, Stéphan Vagner, Caroline Robert
Cell (2020) Vol. 183, Iss. 4, pp. 860-874
Open Access | Times Cited: 214

Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
Ana Luísa Correia, Joao C. Guimaraes, Priska Auf der Maur, et al.
Nature (2021) Vol. 594, Iss. 7864, pp. 566-571
Closed Access | Times Cited: 208

Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis
Mingming Wu, Xiao Zhang, Weijie Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 96

Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity
Wencheng Wu, Yinying Pu, Heliang Yao, et al.
Nano Today (2022) Vol. 42, pp. 101377-101377
Closed Access | Times Cited: 71

EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?
Azamat Akhmetkaliyev, Noura Alibrahim, Darya Shafiee, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56

Drug-tolerant persister cells in cancer: the cutting edges and future directions
Yi Pu, Lu Li, Haoning Peng, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 799-813
Closed Access | Times Cited: 48

Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives
Alexandra Naba
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 4, pp. 100528-100528
Open Access | Times Cited: 47

Collagens in Cancer: Structural Regulators and Guardians of Cancer Progression
Daniela De Martino, Jose Javier Bravo‐Cordero
Cancer Research (2023) Vol. 83, Iss. 9, pp. 1386-1392
Open Access | Times Cited: 42

Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
Federica Francescangeli, Maria Laura De Angelis, Rachele Rossi, et al.
Cancer and Metastasis Reviews (2023)
Open Access | Times Cited: 40

Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications
Ritama Paul, Jay F. Dorsey, Yi Fan
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107985-107985
Open Access | Times Cited: 93

Evolving cancer–niche interactions and therapeutic targets during bone metastasis
Robert L. Satcher, Xiang H.-F. Zhang
Nature reviews. Cancer (2021) Vol. 22, Iss. 2, pp. 85-101
Open Access | Times Cited: 81

Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy
Fan Zhuang, Qiong Ma, Caihong Dong, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 5439-5453
Closed Access | Times Cited: 62

ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung
Ana Rita Nobre, Erica Dalla, Jihong Yang, et al.
Nature Cancer (2022) Vol. 3, Iss. 10, pp. 1165-1180
Open Access | Times Cited: 54

Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence
Patrick Aouad, Yueyun Zhang, Fabio De Martino, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39

Dormant cancer cells: programmed quiescence, senescence, or both?
Kevin Truskowski, Sarah R. Amend, Kenneth J. Pienta
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 37-47
Open Access | Times Cited: 28

Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer
Siyoung Choi, Matthew A. Whitman, Adrian A. Shimpi, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 11, pp. 1455-1472
Closed Access | Times Cited: 21

Correlation between the Warburg effect and progression of triple-negative breast cancer
Shaojun Liu, Yuxuan Li, Meng Yuan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 19

Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency
Moritz Jakab, Ki Hong Lee, Alexey Uvarovskii, et al.
Nature Cancer (2024) Vol. 5, Iss. 5, pp. 716-730
Open Access | Times Cited: 10

Decoding the interplay between genetic and non-genetic drivers of metastasis
Panagiotis Karras, James R. Black, Nicholas McGranahan, et al.
Nature (2024) Vol. 629, Iss. 8012, pp. 543-554
Closed Access | Times Cited: 8

Page 1 - Next Page

Scroll to top